SHANG.FOS.PHARM.GR.H YC 1SHANG.FOS.PHARM.GR.H YC 1SHANG.FOS.PHARM.GR.H YC 1

SHANG.FOS.PHARM.GR.H YC 1

No trades
See on Supercharts

08HH fundamentals

SHANG.FOS.PHARM.GR.H YC 1 financial statements, including revenue, expenses, and profit

The total revenue of 08HH for the last semiannual is 2.77 B EUR, and it's 4.84% higher compared to the previous semiannual. The net income of H2 24 is 208.35 M EUR.

Total revenue
Gross profit
Operating income
Pretax income
Net income
Currency: EUR
TTM
Total revenueYoY growth
Gross profitYoY growth
Pretax incomeYoY growth
Net incomeYoY growth
EBITDAYoY growth
EBITYoY growth